US Stock MarketDetailed Quotes

CMTL Comtech Telecommunications

Watchlist
  • 2.340
  • -1.790-43.34%
Close Jan 13 16:00 ET
  • 2.350
  • +0.010+0.43%
Post 19:58 ET
68.26MMarket Cap-0.24P/E (TTM)

Comtech Telecommunications Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Comtech Telecommunications Q1 2025 Earnings Date

Currency：USDJan 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
125.53M
115.80M
-9.73M
Miss Est.
-17.37%
-23.77%
-7.75%
EPS
-0.48
-5.29
-4.81
Miss Est.
-336.67%
-4709.09%
-1002.31%
Analyst Rating
Buy

Nov 5, 2024

Comtech Telecommunications Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 137.906M--
--2025/Q2-- / 129.525M--
Jan 13, 20252025/Q1115.800M / 125.525M--
Oct 31, 20242024/Q4126.191M / 126.850M--
--2024/Q3128.076M / 136.423M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 137.906M--
--2025/Q2-- / 129.525M--
Jan 13, 20252025/Q1115.800M / 125.525M--
Oct 31, 20242024/Q4126.191M / 126.850M--
--2024/Q3128.076M / 136.423M--

Unlock Free Earnings Estimates

Comtech Telecommunications Earnings Reports

  • Comtech Telecommunications | 10-Q: Q1 2025 Earnings Report

    Jan 13 07:42 ET

  • Comtech Telecommunications | 8-K: COMTECH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF FISCAL 2025

    Jan 13 07:28 ET

  • Comtech Telecommunications | 10-K: FY2024 Annual Report

    Oct 30, 2024 17:32 ET

  • Comtech Telecommunications | 10-Q: Q3 2024 Earnings Report

    Jun 18, 2024 08:18 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +4.06%
    DexCom
    DXCM
    +2.67%
    Collegium Pharmaceutical
    COLL
    +2.67%
    Halozyme Therapeutics
    HALO
    +2.54%
    Constellation Brands
    STZ
    +2.26%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 5, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data